Literature DB >> 7597080

Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues.

T M Jenkins1, A B Hickman, F Dyda, R Ghirlando, D R Davies, R Craigie.   

Abstract

The integrase protein of human immunodeficiency virus type 1 is necessary for the stable integration of the viral genome into host DNA. Integrase catalyzes the 3' processing of the linear viral DNA and the subsequent DNA strand transfer reaction that inserts the viral DNA ends into host DNA. Although full-length integrase is required for 3' processing and DNA strand transfer activities in vitro, the central core domain of integrase is sufficient to catalyze an apparent reversal of the DNA strand transfer reaction, termed disintegration. This catalytic core domain, as well as the full-length integrase, has been refractory to structural studies by x-ray crystallography or NMR because of its low solubility and propensity to aggregate. In an attempt to improve protein solubility, we used site-directed mutagenesis to replace hydrophobic residues within the core domain with either alanine or lysine. The single substitution of lysine for phenylalanine at position 185 resulted in a core domain that was highly soluble, monodisperse in solution, and retained catalytic activity. This amino acid change has enabled the catalytic domain of integrase to be crystallized and the structure has been solved to 2.5-A resolution [Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R. & Davies, D. R. (1994) Science 266, 1981-1986]. Systematic replacement of hydrophobic residues may be a useful strategy to improve the solubility of other proteins to facilitate structural and biochemical studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7597080      PMCID: PMC41641          DOI: 10.1073/pnas.92.13.6057

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus.

Authors:  A T Panganiban; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

2.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

Authors:  F Dyda; A B Hickman; T M Jenkins; A Engelman; R Craigie; D R Davies
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

3.  Requirement of the avian retrovirus pp32 DNA binding protein domain for replication.

Authors:  P J Hippenmeyer; D P Grandgenett
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

4.  The terminal nucleotides of retrovirus DNA are required for integration but not virus production.

Authors:  A T Panganiban; H M Temin
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

5.  Vectors for selective expression of cloned DNAs by T7 RNA polymerase.

Authors:  A H Rosenberg; B N Lade; D S Chui; S W Lin; J J Dunn; F W Studier
Journal:  Gene       Date:  1987       Impact factor: 3.688

6.  Avian sarcoma and leukosis virus pol-endonuclease recognition of the tandem long terminal repeat junction: minimum site required for cleavage is also required for viral growth.

Authors:  D Cobrinik; R Katz; R Terry; A M Skalka; J Leis
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

7.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

8.  Protein volumes and hydration effects. The calculations of partial specific volumes, neutron scattering matchpoints and 280-nm absorption coefficients for proteins and glycoproteins from amino acid sequences.

Authors:  S J Perkins
Journal:  Eur J Biochem       Date:  1986-05-15

9.  Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site.

Authors:  J Colicelli; S P Goff
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

10.  A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration.

Authors:  L A Donehower; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more
  70 in total

Review 1.  Retroviral DNA integration.

Authors:  P Hindmarsh; J Leis
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.

Authors:  J C Chen; J Krucinski; L J Miercke; J S Finer-Moore; A H Tang; A D Leavitt; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Using codon optimization, chaperone co-expression, and rational mutagenesis for production and NMR assignments of human eIF2 alpha.

Authors:  Takuhiro Ito; Gerhard Wagner
Journal:  J Biomol NMR       Date:  2004-04       Impact factor: 2.835

Review 4.  HIV DNA integration.

Authors:  Robert Craigie; Frederic D Bushman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

5.  Application of protein engineering to enhance crystallizability and improve crystal properties.

Authors:  Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-04-21

6.  Synthetic and natural consensus design for engineering charge within an affibody targeting epidermal growth factor receptor.

Authors:  Brett A Case; Benjamin J Hackel
Journal:  Biotechnol Bioeng       Date:  2016-02-04       Impact factor: 4.530

7.  DNA shuffling as a tool for protein crystallization.

Authors:  Robert J Keenan; Daniel L Siehl; Rebecca Gorton; Linda A Castle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

8.  Combining site-specific mutagenesis and seeding as a strategy to crystallize 'difficult' proteins: the case of Staphylococcus aureus thioredoxin.

Authors:  Goedele Roos; Elke Brosens; Khadija Wahni; Aline Desmyter; Silvia Spinelli; Lode Wyns; Joris Messens; Remy Loris
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-30

9.  Structure and activity of human mitochondrial peptide deformylase, a novel cancer target.

Authors:  Sindy Escobar-Alvarez; Yehuda Goldgur; Guangli Yang; Ouathek Ouerfelli; Yueming Li; David A Scheinberg
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

10.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.